MBX Biosciences MBX
NASDAQ MBX
$57.54 +3.91 (+7.29%)
At close: Sep 28, 2026 · 4:00 PM EDT

MBX Biosciences (MBX) EPS (Diluted) (2023 - 2026)

Updated

MBX Biosciences (MBX) recorded EPS (Diluted) of -$0.78 in Q2 2026, compared with -$0.58 a year earlier.

Analysis

MBX Biosciences (MBX) EPS (Diluted) (2023 - 2026) Analysis & Trends

On a TTM basis, MBX Biosciences' EPS (Diluted) came in at -$2.19 as of Jun 30, 2026; for FY2025, it was -$2.38.

  • Across earlier years, EPS (Diluted) came in at -$5.82 in FY2024 and -$31.96 in FY2023.
  • The Q2 2026 figure is the lowest quarterly EPS (Diluted) since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at -$0.50 (Q1 2026), -$0.60 (Q4 2025) and -$0.63 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.27
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 2.04
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -0.54
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 1.67
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 1.85
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 4.37
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -8.44
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 4.31
10 MBX Biosciences 2.57 Bn 2.57 Bn - -0.78
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.78
Mar 31, 2026 -0.50
Dec 31, 2025 -0.60
Sep 30, 2025 -0.63
Jun 30, 2025 -0.58
Mar 31, 2025 -0.71
Dec 31, 2024 -1.46
Sep 30, 2024 -2.78
Jun 30, 2024 -12.62
Mar 31, 2024 -10.26
Dec 31, 2023 -8.68
Sep 30, 2023 -9.40
API Access

MBX Biosciences EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=MBX&period=max&api_key=YOUR_API_KEY